Spring Bank Pharmaceuticals, Inc. (SBPH)
Spring Bank Pharmaceuticals, Inc. (SBPH)
$4.10 USD
Updated Jun 25 8:00pm
Add SBPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 207 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
SBPH News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Tesla (TSLA) shares are down after Electrek says it may miss its 2Q delivery target
Tyson Foods (TSN) shares dive on report that it’s being investigated for price fixing
Shares of marijuana firm Hexo (HEXO) tank following downgrade from Oppenheimer
Why UBS says recent strength in Hostess (TWNK) shares have a lot more upside
Why investors shouldn’t be in a hurry to buy Cronos Group (CRON) shares
View All Top StoriesSpring Bank Pharmaceuticals, Inc. (SBPH) Company Bio
Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of a class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. The company was founded in 2002 and is based in Milford, Massachusetts
SBPH Stock Chart More Charts
SBPH Price/Volume Stats
| Current price | $4.10 |
| Prev. close | $4.06 |
| Day low | $4.02 |
| Day high | $4.18 |
| 50-day MA | $6.14 |
| 200-day MA | $9.77 |
| 52-week high | $15.00 |
| 52-week low | $4.02 |
| Volume | 42,900 |
| Avg. volume | 42,826 |
| Dividend yield | N/A |
| Market Cap | 67.42M |
SBPH Returns
| 1-mo | -37.21% |
| 3-mo | -61.03% |
| 6-mo | -55.04% |
| 1-year | -66.88% |
| 3-year | -58.38% |
| 5-year | N/A |
| YTD | -60.54% |
| 2018 | -22.69% |
| 2017 | 68.21% |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...